A breakthrough treatment evidences much promise for treating type 2 diabetes. It is believed that this treatment may send the treatment into remission. This treatment is derived from the findings of Professors Mike Lean and Roy Taylor of the Institute of Translational and Clinical Research at Newcastle University. They found that a type-2 diabetes is triggered by fat spills. These fat spills, which came from the liver, transported to the nearby pancreas where it created havoc in the efficiency of the organ to produce insulin.
Bolstered by Previous Studies
The clinical investigators summarized from the recent studies that type 2 diabetes is triggered by fat spills. Originated by the liver, the fat spills travel to the nearby pancreas where they trigger havoc on the pancreas and its ability to produce insulin. The researchers uncovered this finding while studying patients who had the disease in the past but placed an emphasis on successfully losing weight and in the process—reversed their conditions. The study was part of the innovative Diabetes Remission Clinical trial study.
NHS takes Action?
The UK’s NHS plans to start a program based on these findings in 2020. The health system will target about 5,000 obese patients to be administered a liquid diet in the form of shake or soup per day. If successful, this experimental program will become the new method of intervention for the chronic ailment that costs the NHS 14 billion pounds per annum—a lot of savings is possible if patients lose weight and push their type-2 diabetes into remission.
Professor Mike Lean, Institute of Translational and Clinical Research at Newcastle University
Professor Roy Taylor, Institute of Translational and Clinical Research at Newcastle University
Call to Action: This finding has significant implications for the United States where many millions have type 2 diabetes.